The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer

Archives of Surgery

Volumn 132, Issue 3, 1997, Pages 264-267

  Sheen Chen, Shyr Ming ^a   Eng, Hock Liew ^a   Chou, Fong Fu ^a   Chen, Wei Jen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ADULT; ANTIGEN DETECTION; ARTICLE; BREAST CANCER; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 0031004245     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430270050010     Document Type: Article

References (19)

1. Riccard A, Danova M, Dionigi P, et al. Cell kinetics In leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry. Br J Cancer. 1989;59:898-903.
2. Wright NA, Britton DC, Bone G. et al, An In vivo stathmokinetic study of cell proliferation in human gastric carcinoma and gastric mucosa. Cell Tissue Kinet 1977;10:429-436.
3. Ohyama S, Yonemura Y, Miyazaki I. Prognostic value of S-phase fraction and DMA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Cancer. 1990;65:116-129.
4. Tanigawa N, Masuda Y, Shimomatsuya T, Fujii H, Muraoka R, Tanaka T. Thymidine uptake in vitro as a prognostic indicator for primary gastric cancer. Cancer. 1993;72:2883-2888.
5. Hall PA, Woods AL. Immunohistological markers of cell proliferation: achievements, problems, and prospects. Cell Tiss Kinet. 1990;23:531-549.
6. Keshgegian AA, Cnaan A, Proliferation markers in breast carcinoma: mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, ki-67 and MIB-1, Am J Clin Pathol. 1995;104:42-49.
7. Mathews MB, Bernstein RM, Franza BR, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature. 1984;309:374-376.
8. Ng IL, Lai ECS, Fan ST, Ng M, Chan ASY, So MKP. Prognostic significance of proliferating cell nuclear antigen expression in hepato-cellular carcinoma. Cancer. 1994;73:2268-2274.
9. Mori M, Kakeji Y, Adachi Y, et al. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery. 1993;113:683-690.
10. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer. 1957;11:359-377.
11. Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983;31:1333-1335.
12. Consensus conference: adjutant chemotherapy for breast cancer. JAMA. 1985;254:3461-3463.
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
14. Henry JA, McCarthy AL, Angus B, et al. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: an immunohistochemical study. Cancer. 1990;65:265-271
15. Tetu B, Brisson J. Progonostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer: the influence of the pattern of immunostaining and adjuvant therapy. Cancer. 1994;73:2359-2365.
16. Cardiff RD. Cathepsin D and breast cancer: useful? Hum Pathol. 1994;25:847-848.
17. Tahan SR, Neuberg DS, Dieffenbach A, Yacoub L. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer. 1993;71:3552-3559.
18. Aaltomaa S, Lipponen P, Syrjanen K. Prognostic value of cell proliferation In breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining. Anticancer Res. 1992;12:1281-1286.
19. Blanchi S, Paglierani M, Zampi G. et al. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients. Cancer. 1993;72:120-125.